Oncology
We specialize in the production of innovative oncology research models including PDX models and compound evaluation using PDX or cell line xenograft models, and efficacy testing of cancer immunotherapeutics.
我们为肿瘤学、免疫学和神经生物学领域的基础研究和新疗法的发展提供最终解决方案; 为您的研究提供最可靠、有创新性的临床前人源化动物模型及其功能有效性评估服务.
We specialize in the production of innovative oncology research models including PDX models and compound evaluation using PDX or cell line xenograft models, and efficacy testing of cancer immunotherapeutics.
Our preclinical testing facility specializes in the production of cutting-edge immunological research models including humanized CD34+and PBMC mice and compound evaluation of standardized preclinical models of autoimmune and inflammatory diseases.
We offer a diverse set of efficacy – testing capabilities and compound evaluation in the areas of muscular dystrophy and neurodegeneration.
Over 300 patient-derived xenograft (PDX) tumors are available for engrafting into immunocompromised NSG™ mice for shipment to your facility or use in JAX-directed preclinical efficacy studies.
Humanized mouse models are powerful tools for studying cancer, inflammatory and infectious disease, and hematopoiesis. We provide fast access to study-ready cohorts.
We evaluate the pharmacokinetics, bioavailability and efficacy of therapeutic monoclonal antibodies in vivo, using unique JAX-generated FcRn-humanized models.
We use cookies to personalize our website, enable social media features and interactivity and to analyze web traffic to improve the user experience. You may decline these cookies although certain areas of the site may not function without them. Please refer to our privacy policy for more information.
Essential
These cookies are required for basic site operations.
Analytics
Analytics cookies are used to analyze web traffic to improve the user experience.
Marketing
Marketing cookies are used to enable social media features, personalize content and improve site interactivity.